Hemant Surgical Industries Limited

Hemant Surgical Industries Limited IPO Review, Date, Price, GMP, Allotment

Hemant Surgical Industries Limited is a midsized company that was established in 1985 in Mumbai, Maharashtra, India. Its main objective is to import, manufacture, and market high-quality surgical and pharmaceutical products at affordable prices.

In 1989, the company was incorporated as Hemant Surgical Industries Limited and became the sole agent for IMS Co., Ltd, Japan. It also became an authorized agent for IMS Singapore Pte Ltd, Singapore. Over the past 30 years, Hemant Surgical Industries Limited has worked diligently and has gained recognition as a leading brand in the medical fraternity for its delivery of medical products.

With over 20 years of experience, Hemant Surgical Industries Limited successfully installed more than 3,000 hemodialysis machines across India. In addition to hemodialysis machines, the company imports various dialysis accessories, including hemodialyzers, bloodline tubing, AV fistula needles, transducer protectors, and catheters.

To further expand its operations, the company established a manufacturing plant at Acchad Industrial Estate, Accahd, District Thane, India. This plant focuses on the production of hemodialysis fluid, hot/cold disinfectants, sanitizers, and other related products. All equipment and machinery at the plant are fully automatic, minimizing human interference and contact.

Recognizing the growing population in India and the increasing pollution due to industrial development, Hemant Surgical Industries Limited identified an opportunity to market asthmatic and healthcare products. Consequently, the company invested in and set up a second manufacturing plant in Atgaon, Taluka Shahpur, Dist. Thane. This plant manufactures nebulizers, oxygen concentrators, air mattresses, digital thermometers, pulse oximeters, and 3-ply surgical masks under the brand name “AERO.” The brand has gained significant recognition and appreciation within the medical fraternity across India.

In 2016, Hemant Surgical Industries Limited established its third processing plant in Atgaon to cater to the growing demand for JMS Meditape micropore tape. This plant specializes in rewinding, slitting, and packaging JMS Meditape under the supervision of JMS Co. Ltd, Japan, aiming to address availability and supply issues.

The company proudly announces its fourth manufacturing plant, currently under construction, dedicated to the assembly of SWS Dialysis Machines and JMS (Singapore) products such as intravenous and blood transfusion sets. This state-of-the-art assembly line spans 50,000 square feet and is scheduled for completion in April 2021.

Hemant Surgical Industries Limited is an authorized agent for Feather, a renowned Japanese company specializing in the manufacturing of skin grafting and surgical blades. The company successfully markets Feather products, which are well-accepted across India. Additionally, the company represents a Chinese manufacturer, promoting their all-silicone Foley catheters as a healthier alternative to latex catheters. Through consistent effort, the company has gained a 30% market share on a national level.

Expanding its reach further, the company rents out its dialysis machines to leading nephrologists and engages in profit-sharing joint ventures to run dialysis centers. In 2018, Hemant Surgical Industries Limited acquired its first dialysis center, Sanjeevani Hospital in Malad. The company has also established the London Clinic & Dialysis Center in Nairobi, Kenya, in partnership with a local collaborator. The company’s vision is to open a chain of dialysis centers across India and other countries, aiming to provide quality dialysis at affordable rates.

In line with its international aspirations, Hemant Surgical Industries Limited has started participating in exhibitions outside India, with a specific focus on exporting its hemodialysis equipment and disposables to African and Gulf countries. Through these efforts, the company has gained recognition and success in exporting its products, establishing its presence in the global market. Notably, the company has successfully commissioned more than 45 turnkey dialysis center projects worldwide.

To ensure the quality and standard of its products, Hemant Surgical Industries Limited holds ISO, GMP, and CE certificates for its respective products. These certifications are a testament to the company’s commitment to maintaining high manufacturing and operational standards.

Hemant Surgical Industries Limited IPO Complete Details:

IPO Date24 May 2023 to 26 May 2023
Issue TypeBook Built Issue
Listing AtBSE SME
Face Value10 Rs. Per Share
PriceRs. 85 to 90
Lot Size1600
Issue Size2,760,000 shares (Rs. 24.84 Cr)
Fresh Issue2,760,000 shares (Rs. 24.84 Cr)
Listing Date05 June 2023

Hemant Surgical Industries Limited IPO Timetable:

Opening Date24 May 2023
Closing Date26 May 2023
Allotment31 May 2023
Initiation of Refunds01 June 2023
Credit of Shares to Demat Account02 June 2023
Listing Date05 June 2023
* Date May Change

Company Financial Details:

Period EndedAssetsRevenueProfit After TaxBorrowingsReserves and Surplus
31 March 20214,289.846,065.19114.531,446.35653.38
31 March 20225,437.5910,577.02461.40973.801,114.78
31 March 20236,490.7911,149.68765.11711.921,591.90
Amount In Lakhs

AS OF NOW, the GMP OF Hemant Surgical Industries Limited is Around 64 Rs.

Leave a Reply

Your email address will not be published. Required fields are marked *